60-Day FRN

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 40 / Tuesday, March 2, 2010 / Notices
(FDA). The meeting will be open to the
public.
Name of Committee: Orthopaedic and
Rehabilitation Devices Panel of the
Medical Devices Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on March 23, 2010, from 8 a.m. to
5 p.m.
Location: Hilton Washington DC
North/Gaithersburg, Salons A, B, C and
D, 620 Perry Pkwy., Gaithersburg, MD.
Contact Person: Tracy Phillips, Center
for Devices and Radiological Health,
Food and Drug Administration, 10903
New Hampshire Ave., Silver Spring, MD
20993, 301–796–6150,
[email protected], or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512521. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the agency’s Web
site and call the appropriate advisory
committee hot line/phone line to learn
about possible modifications before
coming to the meeting.
Agenda: On March 23, 2010, the
committee will discuss and make
recommendations on issues relevant to
FDA’s reevaluation of the ReGen
Collagen Scaffold (CS) device (marketed
as the Menaflex®), which FDA cleared
in K082079 on December 18, 2008,
sponsored by ReGen Biologics, Inc. The
indications for use statement for this
device states that the device is intended
for use in surgical procedures for the
reinforcement and repair of soft tissue
injuries of the medial meniscus. In
repairing and reinforcing medial
meniscal defects, the patient must have
an intact meniscal rim and anterior and
posterior horns for attachment of the
mesh. In addition, the surgically
prepared site for the CS must extend at
least into the red/white zone of the
meniscus to provide sufficient
vascularization. The CS reinforces soft
tissue and provides a resorbable scaffold
that is replaced by the patient’s own soft
tissue. The CS is not a prosthetic device
and is not intended to replace normal
body structure.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the

VerDate Nov<24>2008

15:07 Mar 01, 2010

Jkt 220001

meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at http://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present views, orally or in writing, on
issues pending before the committee.
These views may be submitted in
writing to the contact person on or
before March 16, 2010. Oral
presentations from the public will be
scheduled at approximately 1 p.m.,
immediately following lunch. Those
desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the arguments they
wish to present, the names and
addresses of proposed participants, and
an indication of the approximate time
requested to make their presentation on
or before March 8, 2010. Time allotted
for each presentation may be limited. If
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by March 9, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact AnnMarie
Williams, at 301–796–5966, at least 7
days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
http://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: February 24, 2010.
Joanne Less,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–4260 Filed 3–1–10; 8:45 am]
BILLING CODE 4160–01–S

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

9423

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Impact of
Japanese Encephalitis Vaccination in
Cambodia, Funding Opportunity
Announcement (FOA) CK10–003, Initial
Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12 p.m.–2 p.m., May 3,
2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Impact of Japanese Encephalitis
Vaccination in Cambodia, FOA CK10–003.’’
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, GA 30333, Telephone:
(404) 498–2293.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 24, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–4288 Filed 3–1–10; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Agency Information Collection
Activities: African Growth and
Opportunity Act Certificate of Origin
AGENCY: U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 60-Day Notice and request for
comments; Extension of an existing
collection of information: 1651–0082.
SUMMARY: As part of its continuing effort
to reduce paperwork and respondent

E:\FR\FM\02MRN1.SGM

02MRN1

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

9424

Federal Register / Vol. 75, No. 40 / Tuesday, March 2, 2010 / Notices

burden, CBP invites the general public
and other Federal agencies to comment
on an information collection
requirement concerning the African
Growth and Opportunity Act Certificate
of Origin (AGOA). This request for
comment is being made pursuant to the
Paperwork Reduction Act of 1995 (Pub.
L. 104–13; 44 U.S.C. 3505(c)(2)).
DATES: Written comments should be
received on or before May 3, 2010, to be
assured of consideration.
ADDRESSES: Direct all written comments
to U.S. Customs and Border Protection,
Attn: Tracey Denning, Office of
Regulations and Rulings, 799 9th Street,
NW., 7th Floor, Washington, DC 20229–
1177.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to Tracey Denning,
U.S. Customs and Border Protection,
Office of Regulations and Rulings, 799
9th Street, NW., 7th Floor, Washington,
DC 20229–1177, at 202–325–0265.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (Pub. L. 104–13;
44 U.S.C. 3505(c)(2)). The comments
should address: (a) Whether the
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimates of the burden of the
collection of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; (d)
ways to minimize the burden including
the use of automated collection
techniques or the use of other forms of
information technology; and (e) the
annual costs burden to respondents or
record keepers from the collection of
information (a total capital/startup costs
and operations and maintenance costs).
The comments that are submitted will
be summarized and included in the CBP
request for Office of Management and
Budget (OMB) approval. All comments
will become a matter of public record.
In this document CBP is soliciting
comments concerning the following
information collection:
Title: African Growth and
Opportunity Act Certificate of Origin.
OMB Number: 1651–0082.
Form Number: None.
Abstract: The information collected is
used to verify eligibility for duty
preferences under the provisions of
AGOA. It is provided for under 19 CFR
10.214, 10.215, and 10.216. Specifically,
this program provides duty-free

VerDate Nov<24>2008

15:07 Mar 01, 2010

Jkt 220001

treatment under the Generalized System
of Preferences (GSP) to sensitive articles
normally excluded from GSP duty
treatment. It also provides for the entry
of specific textile and apparel articles
free of duty and free of any quantitative
limits from the countries of sub-Saharan
Africa.
Current Actions: This submission is
being made to extend the expiration
date with a change to the burden hours.
Type of Review: Extension (with
change).
Affected Public: Businesses.
Estimated Number of Respondents:
375.
Estimated Time per Respondent: 20
minutes.
Estimated Total Annual Burden
Hours: 8,925.
Dated: February 25, 2010.
Tracey Denning,
Agency Clearance Officer, U.S. Customs and
Border Protection.
[FR Doc. 2010–4287 Filed 3–1–10; 8:45 am]
BILLING CODE 9111–14–P

DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–3308–
EM; Docket ID FEMA–2010–0002]

Oklahoma; Amendment No. 1 to Notice
of an Emergency Declaration
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice.
SUMMARY: This notice amends the notice
of an emergency declaration for the
State of Oklahoma (FEMA–3308–EM),
dated January, 30, 2010, and related
determinations.
DATES:

Effective Date: January, 30, 2010.

FOR FURTHER INFORMATION CONTACT:

Peggy Miller, Disaster Assistance
Directorate, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–3886.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the incident period for
this emergency is closed effective
January, 30, 2010.
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
Individuals and Households In Presidentially

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance—
Disaster Housing Operations for Individuals
and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals
and Households—Other Needs; 97.036,
Disaster Grants—Public Assistance
(Presidentially Declared Disasters); 97.039,
Hazard Mitigation Grant.
W. Craig Fugate,
Administrator, Federal Emergency
Management Agency.
[FR Doc. 2010–4223 Filed 3–1–10; 8:45 am]
BILLING CODE 9111–23–P

DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–1874–
DR; Docket ID FEMA–2010–0002]

Virginia; Major Disaster and Related
Determinations
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice.
SUMMARY: This is a notice of the
Presidential declaration of a major
disaster for the Commonwealth of
Virginia (FEMA–1874–DR), dated
February 16, 2010, and related
determinations.
DATES: Effective Date: February 16,
2010.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Disaster Assistance
Directorate, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–3886.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that, in a letter dated
February 16, 2010, the President issued
a major disaster declaration under the
authority of the Robert T. Stafford
Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121 et seq.
(the ‘‘Stafford Act’’), as follows:

I have determined that the damage in
certain areas of the Commonwealth of
Virginia resulting from a severe winter storm
and snowstorm during the period of
December 18–20, 2009, is of sufficient
severity and magnitude to warrant a major
disaster declaration under the Robert T.
Stafford Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121 et seq. (the
‘‘Stafford Act’’).
Therefore, I declare that such a major
disaster exists in the Commonwealth of
Virginia.
In order to provide Federal assistance, you
are hereby authorized to allocate from funds
available for these purposes such amounts as
you find necessary for Federal disaster
assistance and administrative expenses.

E:\FR\FM\02MRN1.SGM

02MRN1